Rankings
▼
Calendar
COLL Q3 2016 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
Q3 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$408,000
Gross Profit
$379,000
92.9% margin
Operating Income
-$26M
-6480.9% margin
Net Income
-$26M
-6481.4% margin
EPS (Diluted)
$-1.13
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$20M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$99M
Total Liabilities
$24M
Stockholders' Equity
$74M
Cash & Equivalents
$91M
← FY 2016
All Quarters
Q4 2016 →
